LaJolla Pharmaceutical Company drugs

1 result
  • xacduro

    (sulbactam and durlobactam)
    LaJolla Pharmaceutical Company
    XACDURO is indicated for treating hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in adults, caused by susceptible strains of Acinetobacter baumannii-calcoaceticus. It should only be used for infections proven or suspected to be due to these bacteria to prevent drug resistance.